Fundraising FoxAccess BIO
Somerset, US · New Jersey corporation · 1 known investors
Find your way into Access BIO
Sign up to see every warm intro you have to Access BIO
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Access BIO team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Access Bio develops in vitro diagnostics technology, producing rapid diagnostic tests, molecular tests, analyzers, and COVID-19 tests (including PCR, serology, and antigen testing) to detect malaria and other diseases. It serves international public health agencies and organizations.
Founders & leadership
YH
Young Ho ChoiFounder
Board
TS
Tom SabourinBoard director
SJ
Seung Jae BaekBoard director
SH
Sang Hoon KangBoard director
Investors · 1
Reported raises · per SEC filings
Form D private placements$18M disclosed across 2 rounds · 2016–2020
▶$10MraisedNov 2020 · 1 investors · BiotechnologyRule 506(b)
▶$10MraisedNov 2020 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Jinsu JeongDirector
- Young Ae KimExecutive Officer
- Young Ho ChoiExecutive Officer, Director
- Eui Sang HanDirector
- Nam Hyun RyuDirector
- Kueun Hyeong LeeDirector
- Sung-oh ChungDirector
- Offering amount
- $10M
- Amount sold
- $10M
- First sale
- Nov 2020
- Incorporated
- Corporation, New Jersey
- Federal exemptions
- 06b
▶$8MraisedApr 2016 · 1 investors · BiotechnologyRule 506(b)
▶$8MraisedApr 2016 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Young Ho ChoiExecutive Officer, Director
- Tom SabourinDirector
- Seung Jae BaekDirector
- Sang Hoon KangDirector
- Offering amount
- $8M
- Amount sold
- $8M
- First sale
- Mar 2016
- Incorporated
- Corporation, New Jersey
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 2
LabcorpLabCorp provides diagnostic testing services and clinical trial recruitment solutions that connect patient insights to drug development for healthcare providers.
GovdeliveryProvides the Government Experience Cloud (GXC) and Destination Experience Cloud (DXC) platforms, which offer AI-driven, data-based tools and services for public sector digital experiences. Serves governments and destination marketing organizations (DMOs) to help them reach and serve constituents, communities, and destinations.
Companies working in the same space as Access BIO.
Frequently asked questions
- What does Access BIO do?
- Access Bio develops in vitro diagnostics technology, producing rapid diagnostic tests, molecular tests, analyzers, and COVID-19 tests (including PCR, serology, and antigen testing) to detect malaria and other diseases. It serves international public health agencies and organizations.
- Who founded Access BIO?
- Access BIO was founded by Young Ho Choi.
- Who are Access BIO's investors?
- Access BIO's investors include Global Health Investment Corporation.
- How much funding has Access BIO raised?
- Access BIO has disclosed $18M raised across 2 rounds.
- Where is Access BIO headquartered?
- Access BIO is headquartered in Somerset, US.